Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Deciphering Pain Subtypes in Psoriatic Arthritis

EF 2025-26

Résumé
Psoriatic arthritis (PsA) is an inflammatory arthritis occurring in a quarter of patients with psoriasis, an inflammatory skin condition affecting over a million Canadians. Many people with PsA experience persistent pain even when inflammation is controlled, indicating that pain is not always driven by joint inflammation. In some cases, nerve hypersensitivity or broader abnormalities in pain processing may contribute. These pain types are rarely recognized in routine care, leaving clinicians uncertain why symptoms persist despite appropriate anti-inflammatory therapy. My project will examine whether specific pain subtypes are associated with disease activity and if they predict treatment response in individuals starting new therapy for PsA. Patients followed in our specialty PsA clinic will complete validated questionnaires assessing pain characteristics, sleep, fatigue, and mood, allowing us to define pain subtypes and evaluate their relationship with disease activity. In those initiating a new treatment, we will assess if baseline pain subtype predicts improvement over six months. A subset will also undergo specialized sensory testing to measure nerve sensitivity and pain profiling. This integrated approach, combining clinical, psychological, and quantitative nerve-sensitivity assessment, is rarely applied together in PsA research. Expected outcomes include why pain persists in some individuals despite controlled inflammation. Short-term benefits include identifying patients who may benefit from targeted strategies such as pain-processing therapies, sleep interventions, or physical rehabilitation rather than escalation of immunosuppression. Long-term, this work may support personalized PsA management and improve quality of life for people in Canada and worldwide.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
572790
Name
Mehta Pankti
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Deciphering Pain Subtypes in Psoriatic Arthritis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Arthritis; Central Nervous System Sensitization; Chronic Pain; Inflammation; Nociception; Pain Measurement; Precision Medicine; Psoriatic; Rheumatic Diseases; Surveys And Questionnaires; Treatment Outcome
Abstract
Psoriatic arthritis (PsA) is an inflammatory arthritis occurring in a quarter of patients with psoriasis, an inflammatory skin condition affecting over a million Canadians. Many people with PsA experience persistent pain even when inflammation is controlled, indicating that pain is not always driven by joint inflammation. In some cases, nerve hypersensitivity or broader abnormalities in pain processing may contribute. These pain types are rarely recognized in routine care, leaving clinicians uncertain why symptoms persist despite appropriate anti-inflammatory therapy. My project will examine whether specific pain subtypes are associated with disease activity and if they predict treatment response in individuals starting new therapy for PsA. Patients followed in our specialty PsA clinic will complete validated questionnaires assessing pain characteristics, sleep, fatigue, and mood, allowing us to define pain subtypes and evaluate their relationship with disease activity. In those initiating a new treatment, we will assess if baseline pain subtype predicts improvement over six months. A subset will also undergo specialized sensory testing to measure nerve sensitivity and pain profiling. This integrated approach, combining clinical, psychological, and quantitative nerve-sensitivity assessment, is rarely applied together in PsA research. Expected outcomes include why pain persists in some individuals despite controlled inflammation. Short-term benefits include identifying patients who may benefit from targeted strategies such as pain-processing therapies, sleep interventions, or physical rehabilitation rather than escalation of immunosuppression. Long-term, this work may support personalized PsA management and improve quality of life for people in Canada and worldwide.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mehta, Pankti
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~